People from racial and ethnic minorities and other diverse groups are underrepresented in clinical trials. Representation, however, is important because people of different ages, races, and ethnicities may react differently to the same medical product. For example, it is known that some high blood pressure medications don't work well for black adults. Those medications function best under certain conditions, that are reversed in the black adult population. 

​

Lack of diversity also prevents underrepresented populations from enjoying the benefits of clinical trials. People who participate in trials have access to a variety of resources including expert advice, support groups, and health education materials. They also have access to innovative treatments before they go to market. 

​

SUPPORT DIVERSITY IN CLINICAL TRIALS 

Please sign the petition asking your congressional representative to support the existing bi-partisan bills designed to improve diversity in clinical research and expand patient access to medical treatments (Cures 2.0, DEPICT Act, and DIVERSE Act).  And please share this petition in your social media venues!